###begin article-title 0
###xml 9 17 9 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 113 121 <span type="species:ncbi:9606">patients</span>
A shared HLA-DRB1 epitope in the DR beta first domain is associated with Vogt-Koyanagi-Harada syndrome in Indian patients
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
###xml 401 409 401 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 276 281 <span type="species:ncbi:9606">human</span>
###xml 330 338 <span type="species:ncbi:9606">patients</span>
###xml 455 463 <span type="species:ncbi:9606">patients</span>
###xml 502 510 <span type="species:ncbi:9606">patients</span>
###xml 514 522 <span type="species:ncbi:9606">patients</span>
Vogt-Koyanagi-Harada (VKH) disease and sympathetic ophthalmia (SO) are two distinct entities that share common clinical and histopathological features; however, it remains unknown whether they have a common genetic susceptibility. Several studies have shown an association of human leukocyte antigen (HLA)-DR4 with VKH disease in patients of different ethnic backgrounds. We present in this paper the HLA-DRB1 genotyping analysis of a large cohort of VKH patients from southern India and compare these patients to patients with SO and to healthy individuals from the same geographic area.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 304 312 304 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 4 12 <span type="species:ncbi:9606">patients</span>
###xml 109 117 <span type="species:ncbi:9606">Patients</span>
###xml 255 263 <span type="species:ncbi:9606">patients</span>
VKH patients were diagnosed according to the revised criteria of the International Committee on VKH disease. Patients with granulomatous uveitis after ocular trauma or multiple eye surgeries were diagnosed as having SO. Genomic DNA was extracted from all patients and controls. Samples were analyzed for HLA-DRB1 alleles by reverse polymerase chain reaction (PCR) sequence-specific oligonucleotide (SSO) hybridization on microbeads, using the Luminex technology, and by PCR sequence-specific primers (SSP) typing for DRB1*04 allele determination. Strength of associations was estimated by odds ratios (OR) and 95% confidence intervals (CI) and frequencies were compared using the Fisher's exact test.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 95 103 95 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 256 264 256 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 378 386 378 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 396 404 396 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 135 143 <span type="species:ncbi:9606">patients</span>
###xml 292 300 <span type="species:ncbi:9606">patients</span>
###xml 454 462 <span type="species:ncbi:9606">patients</span>
HLA-DRB1 alleles were determined in 94 VKH patients, 39 SO patients, and 112 healthy controls. HLA-DRB1*04 frequency was higher in VKH patients (20.2% versus 10.3% in controls; OR=2.2, p=0.005, pc=0.067). This association was lower than the association of HLA-DRB1*04 frequency in cohorts of patients from different origins. No significant DR4 association with SO was detected. HLA-DRB1*0405 and HLA-DRB1*0410 alleles were significantly increased in VKH patients (8.5% versus 0.9% in controls; OR=10.3, 95% CI=2.34-45.5, p<0.001). These two alleles share the epitope S57-LLEQRRAA (67-74) in the third hypervariable region of the HLA-DR molecule. None of the DRB1 alleles was significantly associated with SO.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 28 36 28 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 46 54 46 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 375 382 372 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR4</italic>
###xml 501 509 498 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 539 547 536 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 337 345 <span type="species:ncbi:9606">patients</span>
###xml 395 402 <span type="species:ncbi:9606">patient</span>
###xml 426 434 <span type="species:ncbi:9606">patients</span>
###xml 619 627 <span type="species:ncbi:9606">patients</span>
###xml 661 669 <span type="species:ncbi:9606">patients</span>
###xml 741 749 <span type="species:ncbi:9606">patients</span>
Based on the association of HLA-DRB1*0405 and HLA-DRB1*0410 alleles with VKH disease, we propose that the epitope S57-LLEQRRAA (67-74) in the third hypervariable region of the HLA-DRbeta1 molecule is the relevant susceptibility epitope. This genetic component seems specific to VKH disease since no correlation could be identified in SO patients. The weaker association with HLA-DR4 in this VKH patient cohort compared to VKH patients from northern India is probably related to the lower frequency of HLA-DRB1*0405 in our study group. The HLA-DRB1 association with susceptibility to VKH syndrome seems weaker in Indian patients compared to Japanese or Hispanic patients, suggesting a different non-HLA immunogenetic background in Indian VKH patients.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 682 683 682 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 827 828 827 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 829 830 829 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
Vogt-Koyanagi-Harada (VKH) disease is a serious ocular inflammatory syndrome characterized by the presence of bilateral panuveitis and exudative retinal detachments. Alopecia, vitiligo, poliosis, tinnitus, and meningeal symptoms may also be present according to the stage of the disease. Several criteria are needed to establish the diagnosis of VKH (e.g., bilateral uveitis, meningismus, and extra-ocular signs). The absence of a history of trauma/surgery is essential. Recently, revised diagnostic criteria were proposed by the First VKH International Workshop group, which classified the disease as complete, incomplete, and probable according to the presence of clinical signs [1]. Some studies have suggested that VKH is a T-lymphocyte-mediated disease and that specific auto-antigens may play a role in its pathogenesis [2,3].
###end p 10
###begin p 11
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
Although VKH and sympathetic ophthalmia (SO) are two distinct entities, they share common clinical features (bilateral granulomatous uveitis) and histopathological signs (infiltration of T-lymphocytes in the choroid and preservation of the choriocapillaris and retina) [4].
###end p 11
###begin p 12
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 353 354 353 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 367 368 367 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 369 370 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 549 557 549 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 627 635 627 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 655 656 655 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 707 715 707 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 722 730 722 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 737 745 737 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 756 764 756 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 908 916 908 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 923 925 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 165 170 <span type="species:ncbi:9606">human</span>
###xml 240 248 <span type="species:ncbi:9606">patients</span>
###xml 451 459 <span type="species:ncbi:9606">patients</span>
###xml 521 529 <span type="species:ncbi:9606">patients</span>
###xml 676 684 <span type="species:ncbi:9606">patients</span>
###xml 834 842 <span type="species:ncbi:9606">patients</span>
Genetic specificities of the human leucocyte antigen (HLA) system have been associated with susceptibility to many autoimmune diseases. The initial discovery of the human leukocyte antigen (HLA)-DR4 association with VKH disease in Japanese patients [5] has been confirmed in several subsequent studies including Chinese [6], North American [7], Korean [3], Japanese [8,9], Italian [10], Hispanic [11], Mestizos [12,13], and strongly admixed Brazilian patients [14]. In several reports, the higher frequency of DR4 in VKH patients was related to the HLA-DRB1*0405 allele, and in three Japanese studies a significant increase in HLA-DRB1*0410 was observed [8,15,16]. In Mestizo patients, gene frequencies for HLA-DRB1*0102, HLA-DRB1*0404, HLA-DRB1*0407, and HLA-DRB1*0410 alleles were higher than in controls [13]. A recent study on 30 patients from Saudi Arabia reported a significant association of VKH with HLA-DRB1*0405 [17].
###end p 12
###begin p 13
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
In the present article, we examined the frequency of HLA-DRB1 alleles in a large cohort of VKH patients from southern India and compared this with patients with SO and healthy individuals from the same geographic area.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Study samples
###end title 15
###begin p 16
###xml 33 41 <span type="species:ncbi:9606">patients</span>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
We prospectively included 94 VKH patients, 39 SO patients, and 112 healthy subjects. All patients with VKH and SO were examined at the Uveitis Clinic of the Aravind Eye Hospital, Madurai, India.
###end p 16
###begin p 17
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 209 217 <span type="species:ncbi:9606">patients</span>
###xml 622 630 <span type="species:ncbi:9606">patients</span>
Patients were diagnosed with VKH according to the revised criteria of the International Committee on VKH disease [1]. In the absence of a history of trauma/surgery and after exclusion of other uveitis causes, patients presenting with bilateral uveitis with exudative retinal detachment and a history of meningismus, CSF pleocytosis, or sensorineural deafness with integumentary changes were diagnosed as having complete VKH. Incomplete VKH was diagnosed in the presence of either signs or symptoms of central nervous system (CNS) involvement or integumentary changes. In the absence of both CNS and integumentary changes, patients were diagnosed as having probable VKH syndrome.
###end p 17
###begin p 18
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 126 133 <span type="species:ncbi:9606">patient</span>
Patients presenting with granulomatous uveitis after ocular trauma or multiple eye surgeries were diagnosed with SO. For each patient other causes of granulomatous uveitis were excluded by an extensive work-up.
###end p 18
###begin p 19
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 4 12 <span type="species:ncbi:9606">patients</span>
###xml 446 458 <span type="species:ncbi:9606">participants</span>
All patients had a complete eye examination, including Snellen visual acuity, slit-lamp biomicroscopy, tonometry, and dilated fundus examination. Intraocular inflammation was graded according to the International Uveitis Study Group recommendations [18]. Demographic data included gender, present age, and age at onset of VKH or SO. The present study was approved by the local Ethics Committee, and written informed consent was obtained from all participants.
###end p 19
###begin title 20
Analytical methods
###end title 20
###begin p 21
###xml 103 111 103 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 566 574 566 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 759 767 759 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
For each subject a blood sample was taken and genomic DNA was extracted. All samples were analyzed for HLA-DRB1 alleles by reverse polymerase chain reaction (PCR) sequence-specific oligonucleotide (SSO) reverse hybridization on microbead arrays (Luminex technology; Luminex Corporation, Austin, TX) after locus-specific amplification on genomic DNA samples, using LabType RSSO2B reagents (OneLambda, Ingen, Chilly Mazarin, France). This assay provided results at an intermediate level (groups of alleles), with assignment of the four-digit allele in some cases. The HLA-DRB1*04-positive samples were subtyped by PCR sequence-specific primers (PCR-SSP; Genovision, Milan Analytika AG, Magden, Switzerland). Intermediate resolution level data were expressed as HLA-DRB1 two-digit types.
###end p 21
###begin title 22
Statistical analysis
###end title 22
###begin p 23
Group comparison proceeded with the Fisher's exact test for gender and disease severity and the Kruskal-Wallis test for age. Comparison of allele frequencies was performed with the Fisher's exact test. The strength of the associations was estimated by odds ratios (OR) and 95% confidence intervals (CI). Haldane's correction was used when a value was zero in a 2x2 table. The threshold for statistical significance was set at p=0.05, and all tests were two-sided. P-values were corrected according to Bonferroni (pc, corrected p-value) when multiple comparisons were made. Statistical analysis was performed with the SPSS software, version 17 (SPSS Inc., Chicago, IL).
###end p 23
###begin title 24
Results
###end title 24
###begin p 25
###xml 16 23 16 23 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 71 79 <span type="species:ncbi:9606">patients</span>
###xml 123 131 <span type="species:ncbi:9606">patients</span>
###xml 236 244 <span type="species:ncbi:9606">patients</span>
As indicated in Table 1, 245 subjects were recruited, including 94 VKH patients (median age 40 years; 73.4% female), 39 SO patients (median age 45 years; 43.6% female;) and 112 healthy controls (median age 56 years; 37.5% female;). All patients and controls were Indian Tamils.
###end p 25
###begin title 26
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient characteristics.
###end title 26
###begin p 27
The asterisk indicates Fisher's exact test for proportions; Kruskal-Wallis test for age. The sharp (hash mark) indicates missing values (n=5 in VKH; n=4 in SO).
###end p 27
###begin p 28
###xml 22 30 22 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 152 159 152 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 162 170 162 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 409 417 409 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 224 232 <span type="species:ncbi:9606">patients</span>
###xml 333 341 <span type="species:ncbi:9606">patients</span>
###xml 428 436 <span type="species:ncbi:9606">patients</span>
###xml 499 507 <span type="species:ncbi:9606">patients</span>
We first compared the HLA-DRB1 intermediate resolution typing results among the three study groups. When considering two-digit allele type frequencies (Table 2), HLA-DRB1*04 displayed a frequency about twofold higher in VKH patients than in controls (20.2% versus 10.3%, OR=2.2, p=0.005, pc=0.067). All other differences between VKH patients and controls were nonsignificant, including the lower frequency of HLA-DRB1*15 in VKH patients (19.1% versus 26.3%, OR=0.66, p=0.10). Comparisons between SO patients and controls did not reveal any significant association.
###end p 28
###begin title 29
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
###xml 82 90 <span type="species:ncbi:9606">patients</span>
HLA-DRB1 frequencies (generic DR types) in patients with VKH syndrome compared to patients with SO and to healthy controls.
###end title 29
###begin p 30
The dagger indicates Fisher's exact test. The sharp (hash mark) indicates Bonferroni correction for multiple comparisons pc=0.067 (n=13). n.a. indicates not applicable.
###end p 30
###begin p 31
###xml 90 98 90 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 130 138 <span type="species:ncbi:9606">patients</span>
###xml 152 160 <span type="species:ncbi:9606">patients</span>
###xml 227 235 <span type="species:ncbi:9606">patients</span>
Similar results were obtained when genotype frequencies were considered (data not shown). HLA-DRB1*04 was present in 37.2% of VKH patients, 25.6% of SO patients, and 19.6% of controls, with a significant difference between VKH patients and controls (OR=2.4, p=0.008, pc=0.094).
###end p 31
###begin p 32
###xml 46 49 46 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DR1</italic>
###xml 54 57 54 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DR4</italic>
###xml 67 74 67 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 128 136 128 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 142 150 142 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 253 261 253 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 267 275 267 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 285 293 285 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 469 477 462 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 487 495 480 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 501 509 494 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 569 577 562 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 583 591 576 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 604 612 597 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 618 626 611 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 671 679 664 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 685 693 678 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 171 179 <span type="species:ncbi:9606">patients</span>
###xml 394 402 <span type="species:ncbi:9606">patients</span>
We then considered high-resolution typing for DR1 and DR4 alleles (Table 3). Results showed a significantly higher frequency of HLA-DRB1*0405/HLA-DRB1*0410 alleles in VKH patients than in controls (8.5% versus 0.9%, OR=10.3, p<0.001). As illustrated in Figure 1, the HLA-DRB1*0405 and HLA-DRB1*0410 alleles share the S57-LLEQRRAA (67-74) epitope in the alpha-1 domain of the DR beta-chain. VKH patients also showed a slightly, but nonsignificantly, higher frequency of HLA-DRB1*0101 and HLA-DRB1*0403/HLA-DRB1*0407 alleles, which share the LLEQRRA (67-73) epitope with HLA-DRB1*0405/HLA-DRB1*0410, while HLA-DRB1*0403/HLA-DRB1*0407 differ at residue 74 (Ala versus Glu). HLA-DRB1*0405/HLA-DRB1*0410 showed no significant association with SO disease.
###end p 32
###begin title 33
###xml 25 33 25 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
Genotypic frequencies of HLA-DRB1 alleles within the DR1 and DR4 specificities.
###end title 33
###begin p 34
The dagger indicates Fisher's exact test. The sharp (hash mark) indicates Bonferroni correction for multiple comparisons pc=0.017 (n=5). n.a. indicates not applicable.
###end p 34
###begin p 35
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-DRB1</italic>
###xml 291 299 291 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 306 314 306 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 321 329 321 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 336 344 336 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 351 359 351 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 366 374 366 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 381 389 381 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 396 404 396 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 411 419 411 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 426 434 426 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 445 453 445 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 124 132 <span type="species:ncbi:9606">patients</span>
The third hypervariable region sequence of the human leukocyte antigen (HLA)-DRB1 first domain of the alleles identified in patients and controls. Residues 51-80 are represented. In addition to the alleles included in the figure, the following rare alleles were also observed in this study: HLA-DRB1*0305, HLA-DRB1*0407, HLA-DRB1*0804, HLA-DRB1*1106, HLA-DRB1*1111, HLA-DRB1*1415, HLA-DRB1*1506, HLA-DRB1*1507, HLA-DRB1*1509, HLA-DRB1*1514, and HLA-DRB1*1602. Amino acid sequences are shown using the one-letter code. The epitope S57-LLEQRRAA (67-74) is highlighted.
###end p 35
###begin p 36
###xml 81 89 81 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 95 103 95 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 137 145 <span type="species:ncbi:9606">patients</span>
###xml 158 166 <span type="species:ncbi:9606">patients</span>
###xml 232 240 <span type="species:ncbi:9606">patients</span>
Results were similar when genotype frequencies were considered (data not shown). HLA-DRB1*0405/HLA-DRB1*0410 was present in 17.0% of VKH patients, 7.7% of SO patients, and 1.8% of controls, with a significant difference between VKH patients and controls (OR=11.3, p<0.001).
###end p 36
###begin p 37
###xml 73 81 73 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 87 95 87 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Disease severity could be assigned for 89 VKH patients. The frequency of HLA-DRB1*0405/HLA-DRB1*0410 alleles was slightly higher in more severe disease conditions, but the difference was not significant (9.4% versus 7.5%, p=1).
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 71 79 71 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 85 93 85 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 188 195 188 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 305 313 302 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 495 503 492 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 588 595 585 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 129 137 <span type="species:ncbi:9606">patients</span>
###xml 565 573 <span type="species:ncbi:9606">patients</span>
In the present study, we found a significantly higher frequency of the HLA-DRB1*0405/HLA-DRB1*0410 alleles in a cohort of 94 VKH patients from southern India compared to healthy controls (Table 3). We propose that the epitope S57-LLEQRRAA (67-74) in the third hypervariable region of the DR beta-1-chain (Figure 1) could be relevant to the susceptibility to VKH syndrome. In this cohort, residue S57 alone could not account for the susceptibility, as proposed previously [8], since S57-positive HLA-DRB1*08 allele frequency did not significantly differ between VKH patients and controls (Table 2).
###end p 39
###begin p 40
###xml 59 67 59 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 77 85 77 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 91 99 91 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 267 274 264 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 276 284 273 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 377 379 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 448 450 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 493 501 490 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 507 515 504 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 572 574 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 431 438 <span type="species:ncbi:9606">patient</span>
###xml 562 570 <span type="species:ncbi:9606">patients</span>
Alternatively, if the weak association of VKH disease with HLA-DRB1*0101 and HLA-DRB1*0403/HLA-DRB1*0407 is considered as relevant, the susceptibility epitope shared by the five alleles would be LLEQRRA (67-73) in the third hypervariable region of DRbeta1 molecules (Table 3, Figure 1). This epitope exhibits considerable similarity to the rheumatoid arthritis-shared epitope [19]. The observed association of VKH with DR1 in some patient cohorts [13] would support this possibility, although HLA-DRB1*0403/HLA-DRB1*0407 were not increased among 48 Japanese VKH patients [15].
###end p 40
###begin p 41
###xml 40 48 40 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 54 62 54 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 96 104 96 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 110 118 110 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 124 132 124 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 138 146 138 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 152 160 152 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 277 285 277 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 295 303 295 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 381 389 381 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 395 403 395 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 333 341 <span type="species:ncbi:9606">patients</span>
Because the association between VKH and HLA-DRB1*0405/HLA-DRB1*0410 was much stronger than with HLA-DRB1*0101/HLA-DRB1*0403/HLA-DRB1*0405/HLA-DRB1*0407/HLA-DRB1*0410 (OR 10.3 versus 2.4) in the present study, our data favor the hypothesis of a susceptibility epitope shared by HLA-DRB1*0405 and HLA-DRB1*0410 alleles in south Indian patients. The nonpolar alanine at residue 74 of HLA-DRB1*0405/HLA-DRB1*0410 could be crucial in increasing the affinity of antigenic peptide(s) to the HLA-DR4 molecule and/or T cell receptor recognition. A role of Ser at position 57, predicted to point toward the peptide-binding cleft, should also be considered.
###end p 41
###begin p 42
###xml 56 64 56 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 70 78 70 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 208 216 208 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 222 230 222 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 365 369 365 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DQB1</italic>
###xml 416 424 416 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 430 438 430 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 503 507 503 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DQB1</italic>
###xml 27 35 <span type="species:ncbi:9606">patients</span>
###xml 239 247 <span type="species:ncbi:9606">patients</span>
###xml 489 497 <span type="species:ncbi:9606">patients</span>
In a cohort of 57 Japanese patients, the association of HLA-DRB1*0405/HLA-DRB1*0410 was stronger with prolonged than nonprolonged VKH disease [16]. Our results similarly showed a slightly higher frequency of HLA-DRB1*0405/HLA-DRB1*0410 in patients with severe compared to moderate disease conditions, but the difference was not statistically significant. A role of DQB1*0402, which is in linkage disequilibrium with HLA-DRB1*0405/HLA-DRB1*0410, seems unlikely because 40% of 15 tested VKH patients were DQB1*0402 negative (data not shown).
###end p 42
###begin p 43
###xml 434 442 434 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 631 639 631 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 721 729 721 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 739 747 739 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 137 145 <span type="species:ncbi:9606">patients</span>
###xml 272 280 <span type="species:ncbi:9606">patients</span>
###xml 372 380 <span type="species:ncbi:9606">patients</span>
The HLA-DR susceptibility epitope could slightly differ in populations with different genetic backgrounds. Accordingly, south Indian VKH patients in the present study might be closer to other Asian cohorts than to Hispanics. However, in a recent study of North Indian VKH patients, no association with DR4 was observed, which is possibly related to the high prevalence of patients with incomplete syndrome and to the low frequency of HLA-DRB1*0405 in this population [20,21]. When compared with a north Indian population [20], the present south Indian control population was characterized by a twofold higher relative frequency of HLA-DRB1*0403 (69.6% versus 34.8% in the north Indian population), whereas frequencies of HLA-DRB1*0405 and HLA-DRB1*0410 were lower (4.3% versus 11.2%) and comparable (4.3% versus 3.4%), respectively.
###end p 43
###begin p 44
###xml 76 84 76 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 90 98 90 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 605 613 605 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 400 408 <span type="species:ncbi:9606">patients</span>
###xml 578 586 <span type="species:ncbi:9606">patients</span>
Even though the present results reveal a strong association of VKH with the HLA-DRB1*0405/HLA-DRB1*0410 alleles, the frequency of these two alleles was relatively low in this south Indian population. In conclusion, although highly significant, the immunogenetic basis of HLA-DRB1 associations with susceptibility to VKH syndrome seems to be weaker in south Indian Tamils than in Japanese or Hispanic patients. Additional genetic systems, such as killer immunoglobulin-like receptor-HLA interactions could also play a role, as suggested recently in a small cohort of Mestizo VKH patients [22]. Finally, no HLA-DRB1 association could be observed with SO, which is in accordance with the clearly different physiopathology of both diseases.
###end p 44
###begin title 45
Acknowledgments
###end title 45
###begin p 46
We are grateful to Claire Desaules for her expert technical assistance. This work was supported by grant Ndegrees 320000-112585 from the Swiss National Science Foundation.
###end p 46
###begin title 47
References
###end title 47
###begin article-title 48
Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature.
###end article-title 48
###begin article-title 49
###xml 38 46 <span type="species:ncbi:9606">patients</span>
###xml 91 96 <span type="species:ncbi:9606">human</span>
Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens.
###end article-title 49
###begin article-title 50
Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans.
###end article-title 50
###begin article-title 51
Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome.
###end article-title 51
###begin article-title 52
HLA and Vogt-Koyanagi-Harada syndrome.
###end article-title 52
###begin article-title 53
###xml 10 15 <span type="species:ncbi:9606">human</span>
Profiling human leukocyte antigens in Vogt-Koyanagi-Harada syndrome.
###end article-title 53
###begin article-title 54
HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia.
###end article-title 54
###begin article-title 55
HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410.
###end article-title 55
###begin article-title 56
Complete association of the HLA-DRB1*04 and -DQB1*04 alleles with Vogt-Koyanagi-Harada's disease.
###end article-title 56
###begin article-title 57
###xml 52 60 <span type="species:ncbi:9606">patients</span>
VogtKoyanagi-Harada disease and HLA type in Italian patients.
###end article-title 57
###begin article-title 58
###xml 82 90 <span type="species:ncbi:9606">patients</span>
Association between Vogt-Koyanagi-Harada syndrome and HLADR1 and -DR4 in Hispanic patients living in southern California.
###end article-title 58
###begin article-title 59
###xml 83 91 <span type="species:ncbi:9606">patients</span>
HLA-DR is strongly associated with Vogt-Koyanagi-Harada disease in Mexican Mestizo patients.
###end article-title 59
###begin article-title 60
###xml 38 46 <span type="species:ncbi:9606">patients</span>
HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt-Koyanagi-Harada's disease in Southern California.
###end article-title 60
###begin article-title 61
###xml 53 61 <span type="species:ncbi:9606">patients</span>
HLA-DRB1*0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease.
###end article-title 61
###begin article-title 62
###xml 51 59 <span type="species:ncbi:9606">patients</span>
Clinical significance of HLA-DRB1*0410 in Japanese patients with idiopathic thrombocytopenic purpura.
###end article-title 62
###begin article-title 63
HLA class II genes in Vogt-Koyanagi-Harada disease.
###end article-title 63
###begin article-title 64
###xml 15 23 <span type="species:ncbi:9606">patients</span>
HLA-DRB1 among patients with Vogt-Koyanagi-Harada disease in Saudi Arabia.
###end article-title 64
###begin article-title 65
International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease.
###end article-title 65
###begin article-title 66
The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.
###end article-title 66
###begin article-title 67
Heterogeneity of HLA-DRB1*04 and its associated haplotypes in the North Indian population.
###end article-title 67
###begin article-title 68
###xml 60 68 <span type="species:ncbi:9606">patients</span>
HLA typing in Vogt-Koyanagi-Harada syndrome in North Indian patients.
###end article-title 68
###begin article-title 69
KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.
###end article-title 69

